BIOMATICS CAPITAL PARTNERS
Biomatics Capital Partners is a Seattle-based healthcare and life sciences venture firm. Biomatics is a $200 million fund that focuses on early-stage investments, primarily in genomics and digital health. Co-founders and General Partners Dr. Boris Nikolic and Julie Sunderland have invested together in emerging technology, health care, and life science ventures since 2010, leveraging their deep technical knowledge and partnering expertise with an established network of leading academics, pharma executives and venture capital firms.
BIOMATICS CAPITAL PARTNERS
Social Links:
Industry:
Health Care Life Science Venture Capital
Founded:
2016-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Apache Wordpress Plugins
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Polaris Partners
Polaris Partners invests in healthcare and technology companies ​across all stages from founding to profitable growth.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-01-27 | Encodia | Biomatics Capital Partners investment in Series C - Encodia | 75 M USD |
| 2021-01-19 | Verve Therapeutics | Biomatics Capital Partners investment in Series B - Verve Therapeutics | 94 M USD |
| 2020-07-29 | Thrive Earlier Detection | Biomatics Capital Partners investment in Series B - Thrive Earlier Detection | 257 M USD |
| 2020-07-01 | Compass Therapeutics, Inc. | Biomatics Capital Partners investment in Venture Round - Compass Therapeutics, Inc. | 60.48 M USD |
| 2020-06-11 | Verve Therapeutics | Biomatics Capital Partners investment in Series A - Verve Therapeutics | 63 M USD |
| 2020-01-09 | Omniome | Biomatics Capital Partners investment in Series C - Omniome | 60 M USD |
| 2019-11-07 | AiCure | Biomatics Capital Partners investment in Series C - AiCure | 24.5 M USD |
| 2019-11-07 | EGenesis | Biomatics Capital Partners investment in Series B - EGenesis | 100 M USD |
| 2019-06-13 | BlackThorn Therapeutics | Biomatics Capital Partners investment in Series B - BlackThorn Therapeutics | 76 M USD |
| 2019-05-30 | Thrive Earlier Detection | Biomatics Capital Partners investment in Series A - Thrive Earlier Detection | 110 M USD |